PCN9 ERLOTINIB IN NON-SMALL CELL LUNG CANCER (NSCLC) IN...

PCN9 ERLOTINIB IN NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY–A COST-SAVING SECOND-LINE TREATMENT OPTION?

A Gabriel, O Pirk, W Kotowa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Year:
2006
Language:
english
DOI:
10.1016/s1098-3015(10)63439-0
File:
PDF, 72 KB
english, 2006
Conversion to is in progress
Conversion to is failed